| 000 | 01713 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516205100.0 | ||
| 264 | 0 | _c20150115 | |
| 008 | 201501s 0 0 eng d | ||
| 022 | _a1873-3476 | ||
| 024 | 7 |
_a10.1016/j.ijpharm.2014.04.015 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aQian, Shuai | |
| 245 | 0 | 0 |
_aDevelopment, characterization and application of in situ gel systems for intranasal delivery of tacrine. _h[electronic resource] |
| 260 |
_bInternational journal of pharmaceutics _cJul 2014 |
||
| 300 |
_a272-82 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Intranasal |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aChemistry, Pharmaceutical |
| 650 | 0 | 4 |
_aChitosan _xchemistry |
| 650 | 0 | 4 |
_aCholinesterase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Carriers |
| 650 | 0 | 4 | _aGels |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMucociliary Clearance |
| 650 | 0 | 4 |
_aNasal Cavity _xmetabolism |
| 650 | 0 | 4 | _aPhase Transition |
| 650 | 0 | 4 |
_aPoloxamer _xchemistry |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xchemistry |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aRheology |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 |
_aTacrine _xadministration & dosage |
| 650 | 0 | 4 |
_aTechnology, Pharmaceutical _xmethods |
| 650 | 0 | 4 | _aTransition Temperature |
| 700 | 1 | _aWong, Yin Cheong | |
| 700 | 1 | _aZuo, Zhong | |
| 773 | 0 |
_tInternational journal of pharmaceutics _gvol. 468 _gno. 1-2 _gp. 272-82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijpharm.2014.04.015 _zAvailable from publisher's website |
| 999 |
_c23715168 _d23715168 |
||